Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The antibody response to the glycan α-Gal correlates with COVID-19 disease symptoms

  • Urra, José Miguel
  • Ferreras-Colino, Elisa
  • Contreras, Marinela
  • Cabrera, Carmen M.
  • Fernández de Mera, Isabel G.
  • Villar, Margarita
  • Cabezas-Cruz, Alejandro
  • Gortázar, Christian
  • Fuente, José de la
The coronavirus disease 19 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide. The characterization of the immunological mechanisms involved in disease symptomatology and protective response is important to advance in disease control and prevention. Humans evolved by losing the capacity to synthesize the glycan Galα1-3Galβ1-(3)4GlcNAc-R (α-Gal), which resulted in the development of a protective response against pathogenic viruses and other microorganisms containing this modification on membrane proteins mediated by anti-α-Gal IgM/IgG antibodies produced in response to bacterial microbiota. In addition to anti-α-Gal antibody-mediated pathogen opsonization, this glycan induces various immune mechanisms that have shown protection in animal models against infectious diseases without inflammatory responses. In this study, we hypothesized that the immune response to α-Gal may contribute to the control of COVID-19. To address this hypothesis, we characterized the antibody response to α-Gal in patients at different stages of COVID-19 and in comparison with healthy control individuals. The results showed that while the inflammatory response and the anti-SARS-CoV-2 (Spike) IgG antibody titers increased, reduction in anti-α-Gal IgE, IgM and IgG antibody titers and alteration of anti-α-Gal antibody isotype composition correlated with COVID-19 severity. The results suggested that the inhibition of the α-Gal-induced immune response may translate into more aggressive viremia and severe disease inflammatory symptoms. These results support the proposal of developing interventions such as probiotics based on commensal bacteria with α-Gal epitopes to modify the microbiota and increase the α-Gal-induced protective immune response and reduce the severity of COVID-19., This work was partially supported by the Consejería de Educación, Cultura y Deportes, JCCM, Spain, project CCM17-PIC-036 (SBPLY/17/180501/000185). We thank Antonio Mas (University of Castilla La Mancha, UCLM, Spain) for the critical reading of the manuscript. We acknowledge UCLM, Spain support to Grupo SaBio. MC was funded by the Ministerio de Ciencia, Innovación y Universidades, Spain (grant FJC-2018-038277-I). IGFM was supported by the UCLM. MV was supported by the UCLM and the Fondo Europeo de Desarrollo Regional, FEDER, EU.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Coronavirus in cat flea: findings and questions regarding COVID-19

  • Villar, Margarita
  • Fernández de Mera, Isabel G.
  • Artigas-Jerónimo, Sara
  • Contreras, Marinela
  • Gortázar, Christian
  • Fuente, José de la
The coronavirus disease 19 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) has afected millions of people worldwide. Recent evidence raised the question about the possibility that cats may be a domestic host for SARS-CoV-2 with unknown implications in disease dissemination. Based on the fact that the domestic cat fea, Ctenocephalides felis, are abundant ectoparasites infesting humans, companion animals and wildlife and that coronavirus-like agents have been identifed in the ectoparasite tick vector, Ixodes uriae of seabirds, herein we considered the presence of coronaviruses in general and SARS-CoV-2 in particular in C. felis. We identi‑ fed coronavirus-derived and cell receptor angiotensin-converting enzyme RNA/proteins in C. felis. Although cur‑ rent evidence suggests that pets are probably dead-end-hosts with small risk of transmission to humans, our results suggested that cat fea may act as biological and/or mechanical vectors of SARS-CoV. Although preliminary, these results indicate a possibility of ectoparasites acting as reservoirs and vectors of SARS-CoV and related beta-coronavirus although with little disease risk due to systemic transmission route, low viremia, virus attenuation or other unknown factors. These results support the need to further study the role of animal SARS-CoV-2 hosts and their ectoparasite vectors in COVID-19 disease spread., MV was supported by the UCLM and the Fondo Europeo de Desarrollo Regional, FEDER, EU. IGFM was supported by the UCLM. SA-J was supported by a predoctoral fellowship of the UCLM. MC was funded by the Ministerio de Ciencia, Innovación y Universidades, Spain (Grant FJC-2018-038277-I)., Peer reviewed